Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2515/therapie:2008017 | DOI Listing |
Therapie
July 2016
Service de Rhumatologie, Hôpital Charles Nicolle, Tunis, Tunisie.
The aim of this prospective study was to evaluate the data from 29 patients diagnosed as chronic refractory idiopathic thrombocytopenic purpura (ITP) treated with anti-D immunoglobulin and intravenous immunoglobulin G (IVIG). We used anti-D and IVIG in 11 and 18 patients respectively in whom the previous treatments including corticosteroids and splenectomy had been unsuccessful. The complete response rates were significantly higher in IVIG arm (55.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!